UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION;INTREXON CORPORATION
发明人:
申请号：
IL20484110
公开号：
IL204841A
申请日:
2010.04.06
申请国别(地区):
IL
年份:
2014
代理人:
摘要：
This invention provides the field of therapeutics. Most specifically present invention provides methods of generating in vitro engineered dendritic cells conditionally expressing interleukin-12 (IL- 12) under the control of a gene expression modulation system in the presence of activating ligand and uses for therapeutic purposes in animals including human.
